» Articles » PMID: 24719877

Collagen Scaffolds with Controlled Insulin Release and Controlled Pore Structure for Cartilage Tissue Engineering

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2014 Apr 11
PMID 24719877
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Controlled and local release of growth factors and nutrients from porous scaffolds is important for maintenance of cell survival, proliferation, and promotion of tissue regeneration. The purpose of the present research was to design a controlled release porous collagen-microbead hybrid scaffold with controlled pore structure capable of releasing insulin for application to cartilage tissue regeneration. Collagen-microbead hybrid scaffold was prepared by hybridization of insulin loaded PLGA microbeads with collagen using a freeze-drying technique. The pore structure of the hybrid scaffold was controlled by using preprepared ice particulates having a diameter range of 150-250 μ m. Hybrid scaffold had a controlled pore structure with pore size equivalent to ice particulates and good interconnection. The microbeads showed an even spatial distribution throughout the pore walls. In vitro insulin release profile from the hybrid scaffold exhibited a zero order release kinetics up to a period of 4 weeks without initial burst release. Culture of bovine articular chondrocytes in the hybrid scaffold demonstrated high bioactivity of the released insulin. The hybrid scaffold facilitated cell seeding and spatial cell distribution and promoted cell proliferation.

Citing Articles

Advancement in concept to develop biomaterials from agricultural waste for tissue engineering and biomedical applications.

Sah M, Mukherjee S, Flora B, Malek N, Rath S J Environ Health Sci Eng. 2022; 20(2):1015-1033.

PMID: 36406592 PMC: 9672289. DOI: 10.1007/s40201-022-00815-0.


Regenerative Engineering for Knee Osteoarthritis Treatment: Biomaterials and Cell-Based Technologies.

Escobar Ivirico J, Bhattacharjee M, Kuyinu E, Nair L, Laurencin C Engineering (Beijing). 2022; 3(1):16-27.

PMID: 35392109 PMC: 8986132. DOI: 10.1016/j.eng.2017.01.003.


Freeze-Dried Curdlan/Whey Protein Isolate-Based Biomaterial as Promising Scaffold for Matrix-Associated Autologous Chondrocyte Transplantation-A Pilot In-Vitro Study.

Klimek K, Tarczynska M, Truszkiewicz W, Gaweda K, Douglas T, Ginalska G Cells. 2022; 11(2).

PMID: 35053397 PMC: 8773726. DOI: 10.3390/cells11020282.


Potential and recent advances of microcarriers in repairing cartilage defects.

Liao S, Meng H, Li J, Zhao J, Xu Y, Wang A J Orthop Translat. 2021; 27:101-109.

PMID: 33520655 PMC: 7810913. DOI: 10.1016/j.jot.2020.10.005.


Bioactive factors for cartilage repair and regeneration: Improving delivery, retention, and activity.

Patel J, Saleh K, Burdick J, Mauck R Acta Biomater. 2019; 93:222-238.

PMID: 30711660 PMC: 6616001. DOI: 10.1016/j.actbio.2019.01.061.


References
1.
Lu H, Oh H, Kawazoe N, Yamagishi K, Chen G . PLLA-collagen and PLLA-gelatin hybrid scaffolds with funnel-like porous structure for skin tissue engineering. Sci Technol Adv Mater. 2016; 13(6):064210. PMC: 5099770. DOI: 10.1088/1468-6996/13/6/064210. View

2.
Hunziker E . Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage. 2002; 10(6):432-63. DOI: 10.1053/joca.2002.0801. View

3.
Temenoff J, Mikos A . Review: tissue engineering for regeneration of articular cartilage. Biomaterials. 2000; 21(5):431-40. DOI: 10.1016/s0142-9612(99)00213-6. View

4.
Hutmacher D . Scaffolds in tissue engineering bone and cartilage. Biomaterials. 2000; 21(24):2529-43. DOI: 10.1016/s0142-9612(00)00121-6. View

5.
Nesic D, Whiteside R, Brittberg M, Wendt D, Martin I, Mainil-Varlet P . Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliv Rev. 2006; 58(2):300-22. DOI: 10.1016/j.addr.2006.01.012. View